ServiceNow addresses vaccine management challenges
We all have words to describe 2020. Few of them would ring with nostalgia. COVID-19 has created pain, loss, and disruption on a scale not seen in generations. The economy has also been a casualty, as some companies have transformed and thrived while many others have stumbled and dissolved. But then, just as 2020 was bowing out, hope emerged. Three promising vaccines had produced better than expected results in clinical trials. Governments around the world rushed to approve them.